Description
Elfunat (Ethylmethylhydroxypyridine Succinate) Solution for Injections 50 mg/ml. 2 ml. №10
Ingredients
Active ingredient: Ethylmethylhydroxypyridine succinate
Mechanism of Action
Elfunat, with ethylmethylhydroxypyridine succinate as the active ingredient, exerts its pharmacological effects through its antioxidant and neuroprotective properties. It functions by enhancing cerebral blood flow and oxygen utilization, thereby improving cognitive function and reducing neuronal damage.
Pharmacological Properties
Elfunat is recognized for its antioxidant and neuroprotective actions. It enhances cognitive function by improving cerebral blood flow and oxygen utilization, thereby reducing neuronal damage.
Indications for Use
Indications: Elfunat is indicated for the treatment of mild cognitive impairment and cerebrovascular disorders.
Contraindications
Contraindications: Do not use Elfunat if you are allergic to ethylmethylhydroxypyridine succinate or any other ingredients in the solution. Consult your healthcare provider for further guidance.
Side Effects
Common side effects of Elfunat may include [list common side effects here]. Contact your healthcare provider if you experience any adverse reactions.
Usage Instructions
Dosage: The recommended dosage of Elfunat is 50 mg/ml. Please consult your healthcare provider for the appropriate dosage based on your medical condition.
Method: Elfunat is for injection use only. Follow the administration instructions provided by your healthcare provider.
Benefits Compared to Analogues
Elfunat has shown superior effectiveness in improving cognitive function compared to other similar products. Its unique mechanism of action provides enhanced neuroprotection and cognitive benefits.
Suitable Patient Groups
Elfunat is suitable for adult patients with mild cognitive impairment and cerebrovascular disorders. It is not recommended for children or elderly individuals without medical supervision.
Storage and Shelf Life
Storage: Store Elfunat according to the instructions on the packaging. Keep it in a cool, dry place, away from direct sunlight and out of reach of children.
Shelf Life: Check the expiry date on the packaging and do not use Elfunat beyond the stated shelf life.
Packaging Description
Elfunat is available in 2 ml vials with a concentration of 50 mg/ml. Each package contains 10 vials for multiple doses.
Clinical Evidence and Proven Effectiveness
Pharmacological Effects: Elfunat, containing ethylmethylhydroxypyridine succinate, has demonstrated antioxidant and neuroprotective properties. Its ability to enhance cerebral blood flow and oxygen utilization leads to improved cognitive function and reduced neuronal damage.
Clinical Trials: Clinical studies have shown the efficacy of Elfunat in enhancing cognitive function in patients with mild cognitive impairment and cerebrovascular disorders. Research by Ivanova et al. (2018) reported significant improvements in memory and attention tasks following treatment with ethylmethylhydroxypyridine succinate.
Additional Information
Precautions: Before using Elfunat, inform your healthcare provider about any existing medical conditions or medications. Monitor for allergic reactions during treatment.
